NEW YORK (GenomeWeb News) – Allegro Diagnostics has won up to $2.8 million in funding from the National Cancer Institute for clinical studies of its BronchoGen, a molecular diagnostic test for early-stage lung cancer.

The company said today that it will use the Phase I and II Fast Track Small Business Innovation Research funding for a study that will enroll up to 800 patients in 12 sites in the US.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: Icelandic genome sequences, approach to increase CRISPR efficiency, and more.

Testing showing "genetic incompatibilities" have led thousands of couples in Saudi Arabia to call off their weddings, the BBC reports.

Decode Genetics' ability to tell Icelanders, even ones the company hasn't sequenced, about their disease risk brings up ethical questions.

Genetic analysis of Britain's King Richard III and modern descendants of his relatives indicate breaks in the male line.